Abstract
Elucidation of the primary molecular structure of hCG, coupled with monoclonal antibody technology, has permitted the construction of a partial map of hCG surfaces. Based on this information, two-site immunoradiometric assays have been developed which permit the measurement of intact hCG and its subunit molecular forms with unprecedented sensitivity and specificity. These assays have been employed in a determination of the incidence of early pregnancy loss in a normal population with the finding that 22% of all conceptions producing measurable hCG terminate before becoming clinically evident.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
